Alan Hoffman, one of the participants in the first Georgetown University nilotinib trial for PD, has just added a new post to his blog.
If I've understood him correctly, he says that the next trial is planned to begin in January. He also says that Novartis have promised in writing to provide Tasigna for all trial participants after the trial ends.